Summer 2027 Intern, Nucleic Acid & Delivery Research
Bristol Myers Squibb
Summary
Join Research at our Cambridge site for a 10-week, hands-on laboratory internship at the interface of RNA biology, nucleic acid delivery, and cell therapy research. Interns are matched to a project team based on skills and interests. Depending on placement, you will support the design, production, and testing of RNA constructs and the development and characterization of lipid nanoparticle (LNP) formulations for delivery of nucleic acid therapeutics.
Job description
Position Summary
Join Research at our Cambridge site for a 10-week, hands-on laboratory internship at the interface of RNA biology, nucleic acid delivery, and cell therapy research. Interns are matched to a project team based on skills and interests. Depending on placement, you will support the design, production, and testing of RNA constructs and the development and characterization of lipid nanoparticle (LNP) formulations for delivery of nucleic acid therapeutics.
Key Responsibilities
- Design and execute hands-on experiments with supervision, such as in vitro transcription and purification of RNA, formulation of lipid nanoparticles, and cell culture studies to assess performance.
- Evaluate how formulation and process parameters affect quality, consistency, and delivery performance.
- Characterize materials using analytical techniques such as particle sizing (DLS), zeta potential, UV-Vis and fluorescence spectroscopy, and chromatographic or electrophoretic methods.
- Analyze and interpret data using statistical methods and visualization software to guide next experiments.
- Complete timely and thorough documentation in electronic lab notebooks.
- Communicate findings across multiple departments through presentations, written reports, and team discussions.
- Maintain a safe work environment in accordance with policies, procedures, and regulations.
Qualifications & Experience
- Currently enrolled as a junior or senior in an accredited bachelor's program (Master's and PhD students also welcome) in Bioengineering, Biological Sciences, Chemical Engineering, Pharmaceutical Sciences, Chemistry, Biochemistry, or a related field.
- Hands-on laboratory experience through coursework or a previous internship, including proficiency with aseptic technique or general wet-lab operations.
- Relevant experience in an industry or applied research setting is a plus.
- Must be able to work on-site in Cambridge for the full 10-week program.
- All candidates must be legally authorized to work in the United States at the time of hire and for the duration of their employment. Visa sponsorship is not available for this role.
Core Skills
- Exposure to at least one molecular biology or formulation technique (e.g., PCR, RNA extraction, in vitro transcription, nanoparticle formulation).
- Foundational understanding of molecular biology and cell biology; interest in RNA and nucleic acid delivery.
- Strong organization and attention to detail in recording data and executing experiments.
- Ability to work both independently and collaboratively; strong understanding of experimental design and ability to troubleshoot.
- Clear written and verbal communication.
- Curiosity and willingness to learn through hands-on work and mentorship.
Preferred Experience
- Experience analyzing RNA or DNA by chromatography, capillary electrophoresis, qPCR, or sequencing.
- Experience with transfection, electroporation, or other non-viral gene delivery techniques.
- Experience with automated liquid handlers.
- Exposure to statistical design of experiments (DoE) and data analysis tools; familiarity with electronic lab notebooks and Excel.
Requirements
- Currently enrolled as a junior or senior in an accredited bachelor's program (Master's and PhD students also welcome) in Bioengineering, Biological Sciences, Chemical Engineering, Pharmaceutical Sciences, Chemistry, Biochemistry, or a related field
- Hands-on laboratory experience through coursework or a previous internship, including proficiency with aseptic technique or general wet-lab operations
- Must be able to work on-site in Cambridge for the full 10-week program
- Legally authorized to work in the United States at the time of hire and for the duration of employment
- Visa sponsorship is not available; work authorization that does not require sponsorship now or in the future
- Exposure to at least one molecular biology or formulation technique (e.g., PCR, RNA extraction, in vitro transcription, nanoparticle formulation)
- Foundational understanding of molecular biology and cell biology; interest in RNA and nucleic acid delivery
- Strong organization and attention to detail in recording data and executing experiments
- Ability to work both independently and collaboratively; strong understanding of experimental design and ability to troubleshoot
- Clear written and verbal communication
- Curiosity and willingness to learn through hands-on work and mentorship
Benefits
- Comprehensive benefits
- Wellbeing support
- Inclusion initiatives
- Flexibility
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.